{"entity":{"type":"insider","cik":"0001601360","url":"/insider/0001601360","json_url":"/insider/0001601360.json","name":"Gilbert Halley E","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":30,"n_filings":15,"first":"2016-02-26","last":"2025-11-21","span_basis":"filed_date"},"name_variants":[{"name":"Gilbert Halley E","source":"filing","n_filings":15,"first_seen":"2016-02-26","last_seen":"2025-11-21"}],"transactions":[{"id":4333861,"accession":"0001601360-25-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001601360-25-000007","line_url":"/filing/0001601360-25-000007#line-2","is_derivative":false,"issuer_cik":"0001601360","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001601360","owner_cik":"0001601360","owner_name":"Gilbert Halley E","owner_display_name":"Gilbert Halley E","owner_url":"/insider/0001601360","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16532.0,"shares_display":"16,532","price_per_share":27.5491,"price_display":"27.55","price_state":"stated","total_value":455441.7212,"total_display":"455,441.72","total_whole":"455,442","shares_owned_after":22123.0,"shares_owned_after_display":"22,123","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-20","filed_date":"2025-11-21","scope":"insider"},{"id":2222521,"accession":"0001415889-24-015590","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-015590","line_url":"/filing/0001415889-24-015590#line-2","is_derivative":false,"issuer_cik":"0001601360","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001601360","owner_cik":"0001601360","owner_name":"Gilbert Halley E","owner_display_name":"Gilbert Halley E","owner_url":"/insider/0001601360","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18200.0,"shares_display":"18,200","price_per_share":73.0,"price_display":"73.00","price_state":"stated","total_value":1328600.0,"total_display":"1,328,600.00","total_whole":"1,328,600","shares_owned_after":5625.0,"shares_owned_after_display":"5,625","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-03","filed_date":"2024-06-05","scope":"insider"},{"id":2529721,"accession":"0001209191-20-012479","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-012479","line_url":"/filing/0001209191-20-012479","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001601360","owner_name":"Gilbert Halley E","owner_display_name":"Gilbert Halley E","owner_url":"/insider/0001601360","role":"Officer (Chief Admin Officer & SVP)","role_mark":"O","role_mark_label":"Officer (Chief Admin Officer & SVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Admin Officer & SVP","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15328.0,"shares_display":"15,328","price_per_share":11.63,"price_display":"11.63","price_state":"stated","total_value":178264.64,"total_display":"178,264.64","total_whole":"178,265","shares_owned_after":265991.0,"shares_owned_after_display":"265,991","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-21","filed_date":"2020-02-25","scope":"insider","n_lines":4},{"id":2115553,"accession":"0001209191-20-006267","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-006267","line_url":"/filing/0001209191-20-006267#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001601360","owner_name":"Gilbert Halley E","owner_display_name":"Gilbert Halley E","owner_url":"/insider/0001601360","role":"Officer (Chief Admin Officer & SVP)","role_mark":"O","role_mark_label":"Officer (Chief Admin Officer & SVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Admin Officer & SVP","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":12.05,"price_display":"12.05","price_state":"stated","total_value":723000.0,"total_display":"723,000.00","total_whole":"723,000","shares_owned_after":281319.0,"shares_owned_after_display":"281,319","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-31","filed_date":"2020-02-04","scope":"insider"},{"id":7789692,"accession":"0001209191-19-043685","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-043685","line_url":"/filing/0001209191-19-043685#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001601360","owner_name":"Gilbert Halley E","owner_display_name":"Gilbert Halley E","owner_url":"/insider/0001601360","role":"Officer (Chief Admin Officer & SVP)","role_mark":"O","role_mark_label":"Officer (Chief Admin Officer & SVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Admin Officer & SVP","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":200000.0,"total_display":"200,000.00","total_whole":"200,000","shares_owned_after":240169.0,"shares_owned_after_display":"240,169","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-26","filed_date":"2019-07-30","scope":"insider"},{"id":7840441,"accession":"0001209191-19-029605","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-029605","line_url":"/filing/0001209191-19-029605#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001601360","owner_name":"Gilbert Halley E","owner_display_name":"Gilbert Halley E","owner_url":"/insider/0001601360","role":"Officer (Chief Admin Officer & SVP)","role_mark":"O","role_mark_label":"Officer (Chief Admin Officer & SVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Admin Officer & SVP","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4055.0,"shares_display":"4,055","price_per_share":10.53,"price_display":"10.53","price_state":"stated","total_value":42699.15,"total_display":"42,699.15","total_whole":"42,699","shares_owned_after":238240.0,"shares_owned_after_display":"238,240","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-10","filed_date":"2019-05-14","scope":"insider"},{"id":8295299,"accession":"0001209191-19-012643","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-19-012643","line_url":"/filing/0001209191-19-012643","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001601360","owner_name":"Gilbert Halley E","owner_display_name":"Gilbert Halley E","owner_url":"/insider/0001601360","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":85.0,"shares_display":"85","price_per_share":14.32,"price_display":"14.32","price_state":"stated","total_value":1217.2,"total_display":"1,217.20","total_whole":"1,217","shares_owned_after":225152.0,"shares_owned_after_display":"225,152","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-21","filed_date":"2019-02-22","scope":"insider","n_lines":4},{"id":8295285,"accession":"0001209191-19-012643","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-012643","line_url":"/filing/0001209191-19-012643","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001601360","owner_name":"Gilbert Halley E","owner_display_name":"Gilbert Halley E","owner_url":"/insider/0001601360","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10157.0,"shares_display":"10,157","price_per_share":14.31,"price_display":"14.31","price_state":"stated","total_value":145346.67,"total_display":"145,346.67","total_whole":"145,347","shares_owned_after":227824.0,"shares_owned_after_display":"227,824","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-20","filed_date":"2019-02-22","scope":"insider","n_lines":4},{"id":6359073,"accession":"0001209191-18-041567","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-041567","line_url":"/filing/0001209191-18-041567#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001601360","owner_name":"Gilbert Halley E","owner_display_name":"Gilbert Halley E","owner_url":"/insider/0001601360","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29551.0,"shares_display":"29,551","price_per_share":19.75,"price_display":"19.75","price_state":"stated","total_value":583632.25,"total_display":"583,632.25","total_whole":"583,632","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-03","filed_date":"2018-07-05","scope":"insider"},{"id":6393551,"accession":"0001209191-18-012579","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-012579","line_url":"/filing/0001209191-18-012579","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001601360","owner_name":"Gilbert Halley E","owner_display_name":"Gilbert Halley E","owner_url":"/insider/0001601360","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7741.0,"shares_display":"7,741","price_per_share":14.66,"price_display":"14.66","price_state":"stated","total_value":113483.06,"total_display":"113,483.06","total_whole":"113,483","shares_owned_after":94204.0,"shares_owned_after_display":"94,204","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-21","filed_date":"2018-02-22","scope":"insider","n_lines":3},{"id":4109977,"accession":"0001209191-17-041833","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-041833","line_url":"/filing/0001209191-17-041833#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001601360","owner_name":"Gilbert Halley E","owner_display_name":"Gilbert Halley E","owner_url":"/insider/0001601360","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":19.75,"price_display":"19.75","price_state":"stated","total_value":691250.0,"total_display":"691,250.00","total_whole":"691,250","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-22","filed_date":"2017-06-26","scope":"insider"},{"id":5342149,"accession":"0001209191-17-014361","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-014361","line_url":"/filing/0001209191-17-014361","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001601360","owner_name":"Gilbert Halley E","owner_display_name":"Gilbert Halley E","owner_url":"/insider/0001601360","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5039.0,"shares_display":"5,039","price_per_share":16.94,"price_display":"16.94","price_state":"stated","total_value":85360.66,"total_display":"85,360.66","total_whole":"85,361","shares_owned_after":60807.0,"shares_owned_after_display":"60,807","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-22","filed_date":"2017-02-24","scope":"insider","n_lines":2},{"id":4154298,"accession":"0001209191-17-011203","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-011203","line_url":"/filing/0001209191-17-011203#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001601360","owner_name":"Gilbert Halley E","owner_display_name":"Gilbert Halley E","owner_url":"/insider/0001601360","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37385.0,"shares_display":"37,385","price_per_share":16.75,"price_display":"16.75","price_state":"stated","total_value":626198.75,"total_display":"626,198.75","total_whole":"626,199","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-14","filed_date":"2017-02-15","scope":"insider"},{"id":2379039,"accession":"0001209191-16-150218","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-150218","line_url":"/filing/0001209191-16-150218#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001601360","owner_name":"Gilbert Halley E","owner_display_name":"Gilbert Halley E","owner_url":"/insider/0001601360","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14000.0,"shares_display":"14,000","price_per_share":16.75,"price_display":"16.75","price_state":"stated","total_value":234500.0,"total_display":"234,500.00","total_whole":"234,500","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-11","filed_date":"2016-11-15","scope":"insider"},{"id":3292688,"accession":"0001209191-16-124070","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-16-124070","line_url":"/filing/0001209191-16-124070","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001601360","owner_name":"Gilbert Halley E","owner_display_name":"Gilbert Halley E","owner_url":"/insider/0001601360","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20275.0,"shares_display":"20,275","price_per_share":12.19,"price_display":"12.19","price_state":"stated","total_value":247152.25,"total_display":"247,152.25","total_whole":"247,152","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-25","filed_date":"2016-05-27","scope":"insider","n_lines":3},{"id":3289739,"accession":"0001209191-16-103053","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-103053","line_url":"/filing/0001209191-16-103053#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001601360","owner_name":"Gilbert Halley E","owner_display_name":"Gilbert Halley E","owner_url":"/insider/0001601360","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2778.0,"shares_display":"2,778","price_per_share":8.5,"price_display":"8.50","price_state":"stated","total_value":23613.0,"total_display":"23,613.00","total_whole":"23,613","shares_owned_after":36447.0,"shares_owned_after_display":"36,447","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-24","filed_date":"2016-02-26","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":30,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":30,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":30},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001787306","name":"Arcutis Biotherapeutics, Inc.","url":"/issuer/0001787306","role":"Director","n_filings":1,"first_seen":"2025-11-21","last_seen":"2025-11-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001649094","name":"Vaxcyte, Inc.","url":"/issuer/0001649094","role":"Director","n_filings":1,"first_seen":"2024-06-05","last_seen":"2024-06-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001446847","name":"IRONWOOD PHARMACEUTICALS INC","url":"/issuer/0001446847","role":"Officer (Chief Admin Officer & SVP)","n_filings":13,"first_seen":"2016-02-26","last_seen":"2020-02-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001601360","retrieved_at":"2026-08-22T08:59:56+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}